Old Web
English
Sign In
Acemap
>
Paper
>
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
2014
Pranabashis Haldar
Christopher E. Brightling
Amisha Singapuri
Beverley Hargadon
Sumit Gupta
William Monteiro
Peter Bradding
Ruth H. Green
Andrew J. Wardlaw
Hector Ortega
Ian D. Pavord
Keywords:
Prospective cohort study
Interleukin 5
Asthma
Mepolizumab
Reslizumab
Eosinophilic asthma
Immunology
Benralizumab
Medicine
Pulmonary Eosinophilia
Internal medicine
Anesthesia
month follow up
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
125
Citations
NaN
KQI
[]